Navigation Links
Relapse in Risk Management System Claims the Life of Robertson

This report mainly brings to the notice of the common man that how official failings led to a man being bludgeoned to death by a psychiatric patient// with a history of violence. Stuart Robertson was killed by James Smith, who was on conditional discharge from Leverndale Hospital in Glasgow, in October 2004. This report mainly gives us an insight of how there was no systematic approach to risk assessment.

There was a failure to respond adequately to clear signs that Smith's mental illness had relapsed while he was in the care of community-based mental health services. This report was by the Mental Welfare Commission for Scotland. It asks for a series of changes to be implemented by the Scottish Executive, NHS Greater Glasgow and social work chiefs in Glasgow. Smith, 46, had suffered mental problems since 1991. He was jailed for life in Glasgow in November after he admitted the homicide of Mr Robertson.

He had killed Mr Robertson, who also had a history of mental illness, by bludgeoning him to death with a hammer in Pollok Park, Glasgow. The report said that Smith's condition had relapsed in the summer of 2004 but there was no systematic approach to risk assessment in his care and supervision, and an inadequate focus by some of those involved in his care. There was no satisfactory strategy planned to deal with any relapse in his illness.

In the months before the killing he showed signs of relapse but was not recalled to hospital. The Executive, NHS Greater Glasgow and Glasgow City Council acknowledged it had identified weaknesses as the basic risk management was not proper. The deputy health minister, Lewis Macdonald, said that all steps to address the deficiencies identified are being done and the public need not worry about it.


'"/>




Page: 1

Related medicine news :

1. Medications to Prevent Relapse to Cocaine Use
2. Alcoholism Drug Fails To Prevent Drinking Relapses
3. Treatment For Prostate Cancer Relapse Linked To Marital Status
4. New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse
5. Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.
6. Rogue Mammary Stem Cells Could Hold Key To Breast Cancer Relapse
7. Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug
8. Leftover Cancer Cells May Dictate Breast Cancer Relapse
9. Kids are More Prone to Tonsillitis Relapse
10. Colon Cancer Relapse Mainly Caused by Stem Cells
11. ALL Relapses in Most Children After Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... 04, 2016 , ... All-Star Insurance of Northeast TX has ... of their local community. The agency pledges to select a new beneficiary every ... to bring awareness to important local causes with fundraising and other support, by ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... that is transforming breastfeeding for nursing mothers. The company’s patented technology, The Smart ... breastfeeding. Today, the company announced that the technology is now available for purchase ...
(Date:5/4/2016)... ... May 04, 2016 , ... Pharmacy ... announced that it was chosen as the Pharmaceutical News Provider of the Year ... awards acknowledge the hard work and dedication of community members who strive to ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... support for knees, ankles, and elbows. Engineered with athletes in mind, OMNIFORCE ... manufacturing (opposed to ineffective circular knitting, common in the industry) produces premium ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... they acquired Pocono Sterilizer, an equipment sterilization service and sales company located in ... provides medical and research-related equipment and asset management services to the medical and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute lymphocytic Leukemia Market ... to their offering.       (Logo: ... Acute Lymphocytic Leukemia Market and Competitive Landscape ... Lymphocytic Leukemia pipeline products, Acute Lymphocytic Leukemia ...
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
(Date:5/3/2016)... , May 3, 2016 ACME ... Jack Whelan and Delaware County Councilman ... HCI) Nasal Spray in all ACME pharmacies ... Centers for Disease Control and Prevention (CDC), naloxone has saved 26,463 ... police officers in Delaware County were authorized ...
Breaking Medicine Technology: